Increased risk of lung cancer, heart attack from radiotherapy for breast cancer patients who smoke

In a new study published in the Journal of Clinical Oncology, researchers found that smokers treated for breast cancer have a higher risk than non-smokers when it comes to developing lung cancer or heart attack as a result of radiotherapy.

Researchers used data from a worldwide study by the Early Breast Cancer Trialists’ Collaborative Group of the lung and heart radiation doses and risks among women with breast cancer.

Data suggests that for non-smokers, the long-term risk of death from lung cancer or heart attack caused by radiation is only 0.5 percent. However for smokers, the risk is about 5 percent.

The team of researchers also took into account that modern breast care radiotherapy techniques have improved over the years, so they used recent literature when looking at how radiotherapy is being targeted today.

"This research highlights that breast cancer patients who smoke need to be offered help and support in order to try and quit to minimise any risks from their treatment,” said Julie Sharp, head of health information at London's Cancer Research UK, in a statement. “It's important to remember that modern day radiotherapy techniques have been refined and improved to make sure it is targeted and effective while reducing the risk of side effects."

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.